Cantai Therapeutics
PrivateLast Round
Seed
Nov 20, 2023
Company Overview
Cantai Therapeutics is a biotechnology company that develops cytokine-targeting bispecific antibodies for the treatment of autoimmune and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantai Therapeutics Comparables
Compare Cantai Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dualitas Therapeutics | 86% | |
| Navigator Medicines | 86% | |
| Ypsilon Therapeutics | 79% |
Cantai Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 20, 2023 |
Cantai Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Seed |
| Tellus BioVentures | Seed |
| 82VS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2023
Led by 82VS and Agent Capital.
Cantai Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cantai Therapeutics's valuation, stock price, and market status.
Is Cantai Therapeutics a public or private company?
Cantai Therapeutics is a private company.
What is the current stock price of Cantai Therapeutics?
Cantai Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cantai Therapeutics worth (valuation)?
Valuation information for Cantai Therapeutics is not publicly available.
Can I buy Cantai Therapeutics stock?
Cantai Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cantai Therapeutics's last funding round?
Cantai Therapeutics's most recent funding round was Seed on November 20, 2023.
Who are the main investors in Cantai Therapeutics?
Key investors in Cantai Therapeutics include Agent Capital, 82VS.
Will Cantai Therapeutics IPO soon?
No public IPO plans have been announced for Cantai Therapeutics.
How can I track Cantai Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cantai Therapeutics's secondary market activity and sign up for updates.